Warming patients' arms to make veins easier to access for IV treatment
Damaged, hidden or fragile veins can make IV access difficult, especially for older patients and people receiving repeated chemotherapy. Failed attempts can cause distress, delay treatment and waste clinical time. Each failed attempt also requires a new cannula, adding supply and disposal costs.
Airglove Medical supplies an arm-warming system to help clinicians access difficult veins for IV treatment. It circulates warm air through a disposable, double-walled glove, warming the arm in three minutes to prepare veins for cannulation.
What stands out about Airglove Medical
Cambridge University Hospital NHS Foundation Trust purchased four Airglove units for haematology, apheresis and infusion.
An oncology service evaluation at Maidstone and Tunbridge Wells NHS Trust reported 87.5% first-time cannulation success.
Raised £500,000 in equity from lead investor Pulse Angels and co-investor Scottish Enterprise, announced in February 2025.
Airglove identifies NAMA as its US distributor and reports exhibiting with it at the AVA 2026 conference in Texas.
Interface identifies first-generation Airglove Arm as a CE-certified device for patients with difficult intravenous access.
Interface reports a patent estate for Airglove Arm spanning the UK, US, EU, Canada and China.
Secured a £50,000 Innovate UK Fast Start grant to develop Airglove mobile.
Edinburgh Napier University designed, built and tested two Airglove Leg cradle prototypes through a development partnership.
Founder Gio Benedetti built industrial cleaning business ICS and sold it to Initial in 1988.
An Edinburgh Cancer Centre survey with 199 responses reported that 70.59% found Airglove a better cannulation experience.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.